Microbot Medical soars after surgical robot meets main goal in study

Medical device maker Microbot Medical's MBOT.O shares up 50% at $2.08

MBOT says its experimental endovascular robotic system, Liberty, met main goal in the study

Endovascular robotic system assists doctors on minimally invasive surgeries inside blood vessels for treating aneurysms, blockages and other vascular issues

"Mean difference in radiation exposure between operator and control was (-)29.8 µS, resulting in a mean 92% relative reduction in radiation exposure" - MBOT

Some robotic systems use radiation-based imaging techniques, like X-rays or gamma rays

Company says no adverse device events were reported during the study

Up to last close, stock has risen 24.1% YTD